Additional studies have revealed that plasma from patients with severe COVID-19 has increased levels of Cit-H3 and myeloperoxidase-DNA (MPO-DNA) in comparison to patients with classical ARDS [55]. This evidence concerns the gene MPO and acute respiratory distress syndrome.